jRCT2031260282尚未招募不适用
A Multi-center, Double-Blind, Randomized, Two-Arm, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants (FIT-PIV)
未提供0 个研究点目标入组 20 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 26week old over 至 32week old not（—）
- 性别
- All
入选标准
- •Preterm male and female infants born at gestational age 26+0 to 31+6 weeks.
- •Birth weight 500g or more
- •Singleton or twin delivery
- •Up to 5 days after birth (up to 120 hours after birth)
排除标准
- •Infants not dependent on intravenous amino acids/lipids for nutrition
- •Significant congenital malformations
- •Confirmed diagnosis of necrotizing enterocolitis (NEC)
研究者
相似试验
招募中
不适用
A phase IIb, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group, Dose-Ranging Study of M610101 in Patients with Nonsegmental VitiligoNon-segmental vitiligojRCT2031260035120
尚未招募
不适用
A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants With Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis) (VELOTA)Arthritis, PsoriaticjRCT2031250700240
招募中
不适用
A Phase III Study of M610101 in Patients with Atopic DermatitisAtopic dermatitisjRCT2031260244150
招募中
4 期
A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL09112025-523355-59-00Qilu Pharmaceutical Co. Ltd.76
尚未招募
不适用
A Study of Brenipatide in Adult Participants With Major Depressive Disorder (J2S-MC-GZMH)Depressive Disorder, MajorjRCT20212500551,000